Parametric Portfolio Associates’s Repligen RGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding RGEN
BCM
Parametric Portfolio Associates's RGEN Position: Q1 2022 in Review
Parametric Portfolio Associates reduced its Repligen (RGEN) stake by 3.4% in Q1 2022, selling an estimated $902K and leaving 134,617 shares worth $25.3M. The position accounts for 0.01% of the portfolio, ranked #831.
Parametric Portfolio Associates first reported a position in RGEN in Q4 2014 and has held it in 30 quarters since. The position peaked at $39M in Q3 2021. 450 funds tracked by Wall St. Rank hold RGEN as of Q1 2022.
- Parametric Portfolio Associates held 134,617 shares of Repligen worth $25.3M as of Q1 2022.
- Parametric Portfolio Associates sold 4,750 Repligen shares in Q1 2022, an estimated $902K.
- Repligen made up 0.01% of Parametric Portfolio Associates's portfolio in Q1 2022, its #831 holding.
- Parametric Portfolio Associates first reported a position in Repligen in Q4 2014 and has held it in 30 quarters since.
- Parametric Portfolio Associates's Repligen position peaked at $39M in Q3 2021.
- 450 funds tracked by Wall St. Rank held Repligen as of Q1 2022.
Based on Parametric Portfolio Associates's 13F filing for Q1 2022, filed 16 May 2022.